Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in Peripheral Diabetic Neuropathy in Type 2 Diabetes
NCT05977465Phase 2Completed
- Sponsor
- Tanta University
- Start
- Jan 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of empagliflozin in diabetic peripheral neuropathy (DPN), sponsored by Tanta University. Started Jan 2022; status: completed.
02
Drugs
empagliflozin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT05977465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05977465.